Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
Completed · Phase 1 · Has a placebo group
Conditions studied: Degenerative Disc Disease
In brief
The purpose of this study is to compare the safety and preliminary efficacy of intradiscal injections of two doses of IDCT (Discogenic Cells + Sodium Hyaluronate vehicle) and two controls (saline, Sodium Hyaluronate vehicle) in subjects with chronic low back pain due to Degenerative Disc Disease (DDD) at one lumbar level from L3 to S1.
Key facts
- Study ID
- NCT03347708
- Run by
- DiscGenics, Inc.
- People needed
- 60
- Starts
- 2018-02-26
- Expected to finish
- 2022-11-10
- Last updated by the study team
- 2023-01-25
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Alabama Clinical Therapeutics, LLC — Birmingham, Alabama, United States
- University of Southern California — Los Angeles, California, United States
- UC San Diego CIRM Alpha Stem Cell Clinic — San Diego, California, United States
- Source Healthcare — Santa Monica, California, United States
- Otrimed — Edgewood, Kentucky, United States
- Spine Institute of Louisiana — Shreveport, Louisiana, United States
- Orthopedic Center of St. Louis — Chesterfield, Missouri, United States
- Ainsworth Institute of Pain Management — New York, New York, United States
- Carolina Neurosurgery & Spine Associates — Charlotte, North Carolina, United States
- Clinical Investigations, LLC — Edmond, Oklahoma, United States
- Clinical Trials of South Carolina — Charleston, South Carolina, United States
- Semmes Murphey — Memphis, Tennessee, United States
- Physicians' Research Options, LLC — Draper, Utah, United States
- Virginia iSpine — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.